Telephone
61.2.9432.9400
Address
Level 22 161 Castlereagh Street Liberty Place Sydney, New South Wales (NSW) 2000
Description
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.18 - 3.14
Trade Value (12mth)
AU$1,343,973.00
1 week
2%
1 month
-10.65%
YTD
-44.9%
1 year
-44.9%
All time high
9.09515
EPS 3 yr Growth
437.500%
EBITDA Margin
21.80%
Operating Cashflow
$306m
Free Cash Flow Return
9.40%
ROIC
-11.70%
Interest Coverage
6.00
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
615m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
3.75
Date | Announcements |
---|---|
31 May 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
31 March 22 |
Appointment of John Mattick as a Non-executive Director
×
Appointment of John Mattick as a Non-executive Director |
31 March 22 |
Appendix 3X - Initial Director's Interest Notice
×
Appendix 3X - Initial Director's Interest Notice |
31 March 22 |
Notification regarding unquoted securities - HLS
×
Notification regarding unquoted securities - HLS |
31 July 23 |
Webcast details for Healius FY 2023 Results
×
Webcast details for Healius FY 2023 Results |
30 September 22 |
Retirement of Non-executive Director Paul Jones
×
Retirement of Non-executive Director Paul Jones |
30 November 23 |
Appendix 2A
×
Appendix 2A |
30 November 23 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
30 November 23 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
30 November 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
30 May 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
30 August 23 |
Preliminary Final Report
×
Preliminary Final Report |
30 August 23 |
HLS Media Release FY 2023 Results
×
HLS Media Release FY 2023 Results |
30 August 23 |
HLS FY 2023 Results Presentation
×
HLS FY 2023 Results Presentation |
30 August 22 |
Preliminary Final Report
×
Preliminary Final Report |
30 August 22 |
Dividend/Distribution - HLS
×
Dividend/Distribution - HLS |
30 August 22 |
HLS Media Release FY 2022 Results
×
HLS Media Release FY 2022 Results |
30 August 22 |
HLS FY 2022 Results Presentation
×
HLS FY 2022 Results Presentation |
30 August 21 |
FY 2021 Results Presentation
×
FY 2021 Results Presentation |
29 September 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
29 November 23 |
Change in substantial holding from MUFG
×
Change in substantial holding from MUFG |
29 November 23 |
Change in substantial holding
×
Change in substantial holding |
29 November 23 |
Becoming a substantial holder
×
Becoming a substantial holder |
29 March 23 |
TOV: HLS Panel Receives Application
×
TOV: HLS Panel Receives Application |
29 April 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
28 September 22 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
28 September 22 |
Update - Notification of buy-back - HLS
×
Update - Notification of buy-back - HLS |
28 November 23 |
Retail Entitlement Offer opens and Retail Offer Booklet
×
Retail Entitlement Offer opens and Retail Offer Booklet |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.